Aclarion, Inc.
ACON- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001635077
In the last 90 days, Aclarion, Inc. insiders filed 6 open-market purchases and 0 sales; 15 institutions reported holding it in 13F filings for Q2 2026, worth $332.1K in total; no superinvestor holds it.
Other share classesACONW
Q2 2023 vs. Q1 2023
How the institutions holding Aclarion, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 8 | 1 | 13 | +6 |
| Shares | 175.1K | 1.00K | 615.7K | +441.7K (+253.8%) |
| Value | $114.0K | $650 | $423.6K | +$310.3K (+273.8%) |
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Aclarion, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 50,081 | $34.0K | 0.00% |
| Jane Street Group, LLC | 37,517 | $25.9K | 0.00% |
| Virtu Financial LLC | 35,143 | $24.0K | 0.00% |
| Renaissance Technologies LLC | 32,332 | $22.0K | 0.00% |
| Citadel Advisors LLC | 30,170 | $20.8K | 0.00% |
| Commonwealth Equity Services, LLC | 20,430 | $14.0K | 0.00% |
| V Wealth Advisors LLC | 10,000 | $6.90K | 0.00% |
Sold out (1)
Institutions that held Aclarion, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| UBS Group AG | 7,171 | $4.66K |
Not filed for Q2 2023 yet (1)
Institutions that held Aclarion, Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Ahrens Investment Partners LLC | 1,000 | $650 |